Medizone International, Inc.

Medizone International, Inc. Corporate Strategy

Medizone  International  (OTCBB: MZEI) has moved toward product development with lower development costs with the objective of achieving revenue production in the shortest period of time.  The focus is in the field of hospital sterilization. This development pathway is based, in part, on a review of published data on hospital-derived infections, an area of rapidly growing concern in the medical community and subject to increasing governmental oversight and regulation on both a state and federal level in the United States and extensive scrutiny in Canada, the UK and Europe.

Medizone's extensive experience with ozone technologies and its bio-oxidative qualities has contributed greatly in pursuing this initiative. Near term efforts have been directed toward one of the Company's founding tenets, namely that under the right conditions, ozone can be extremely effective at sterilizing virtually all biological fluids  which includes blood, serum, and plasma and its fractionates, as well as all biologically contaminated equipment and spaces.

Medizone is discovering that its unique ozone generating technologies when combined with other new emerging technologies will play a vital role in addressing what public health officials and surgeons world-wide are beginning to recognize as "The Silent Epidemic" silent epidemic: CA-MRSA and HA-MRSA,Richard P. Evans, MD, American Academy of Orthopedic Surgeons, May 2008,  “AAOS Study”, in reference to MRSA (methicillin-resistant staphylococcus aureus) infection.

Hospital Beta Testing

The Company is currently engaged in final preparation for a full scale hospital mock-up trial to be followed by hospital beta testing.

Initial Sales of AsepticSure™

Commencement of commercial deliveries is anticipated early in 2010
Medizone's target is to achieve profitability moving into mid-year 2010

Partnership with Multinational Corporation

Following proof of reliability of the first commercially delivered units, Medizone will have optimized its strengths as a research and development company.  

Medizone International expects to partner with a large corporation embedded in the hospital  sector for increased:

Manufacturing Capacity
Sales
Service